Obesity and Clinical Characteristics of Inflammatory Bowel Disease
Obesity Facts · 2025
DOI: 10.1159/000545436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Facts, 2025. Verfasst von Livia Biancone und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Medicine, Gastroenterology Unit, University "Tor Vergata" of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Body Mass Index, Obesity, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The frequency of obesity and possible correlations with characteristics and outcome of inflammatory bowel disease (IBD) are undefined. Primary aim was to assess the body mass index (BMI) distribution in IBD patients in follow-up. Secondary aim was to compare clinical characteristics and course of IBD in normal weight versus overweight or obese patients.
Methods
Adult IBD patients in regular follow-up were prospectively enrolled and BMI was recorded during outpatient visits. Comparisons were assessed by the Student t-test, Mann-Whitney U test and Chi-square test, as appropriate.
Results
In the 300 IBD patients enrolled (150 Crohn’s disease [CD], 150 ulcerative colitis [UC]), BMI distribution included: 16 (5.3%) underweight, 170 (56.7%) normal weight, 92 (30.7%) overweight, 22 (7.3%) obese patients. For the secondary aim, the 16 underweight patients were excluded, thus leaving 284 patients for the analysis (141 [49.6%] CD; 143 [50.4%] UC). Among these, 114 (40.2%) were overweight/obese and 170 (59.8%) normal weight. CD group included 89 (63.1%) normal weight and 52 (36.9%) overweight/obese patients. Perianal disease and refractoriness to biologics were more frequent in overweight/obese than normal weight CD patients (9 [10.1%] vs. 12 [23%], p = 0.03; 0 [0%] vs. 4 [23.4%], p = 0.01). In UC group, there were 81 (56.6%) normal weight and 62 (63.4%) overweight or obese patients.
Conclusion
In IBD patients in follow-up, the proportion of underweight patients is low. Overweight and obese CD patients showed a higher frequency of perianal disease and refractoriness to biologics. BMI may influence phenotype and responsiveness to biologics in CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Systems Medicine, Gastroenterology Unit, University "Tor Vergata" of Rome, Rome, Italy.
- Department of Systems Medicine, Gastroenterology Unit, University "Tor Vergata" of Rome, Rome, Italy, roberto.mancone@yahoo.it.
Zitieren
APA
Biancone, L., Mancone, R., Biancone, L., Schiavone, S. C., Fiorillo, M., Menna, C., Migliozzi, S., & Neri, B. (2025). Obesity and Clinical Characteristics of Inflammatory Bowel Disease. Obesity Facts. https://doi.org/10.1159/000545436
Vancouver
Biancone L, Mancone R, Biancone L, Schiavone SC, Fiorillo M, Menna C, et al. Obesity and Clinical Characteristics of Inflammatory Bowel Disease. Obesity Facts. 2025. doi:10.1159/000545436
BibTeX
@article{Biancone2025,
author = {Biancone, Livia and Mancone, Roberto and Biancone, Livia and Schiavone, Sara Concetta and Fiorillo, Mariasofia and Menna, Chiara and Migliozzi, Stefano and Neri, Benedetto},
title = {Obesity and Clinical Characteristics of Inflammatory Bowel Disease},
journal = {Obesity Facts},
year = {2025},
doi = {10.1159/000545436}
}
EUVIMED